Trial: 202008005

SRP001: A Phase 1 Study of FSI-189 as Monotherapy and in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Phase

I

Principal Investigator

Bartlett, Nancy

Disease Site

Non-Hodgkin’s Lymphoma

Learn more about this study at: clinicaltrials.gov